For the first time, Merck has granted generic manufacturers, including three African companies, permission to produce an investigational monthly HIV prevention pill, alimatravir,…

South Africa has launched lenacapavir, a groundbreaking HIV prevention medicine, marking a significant moment in the country's fight against the epidemic. This article reflects…